Accelero Receives Authority Permit for SARS-CoV-2 Testing
Berlin, 23 March 2020
Accelero Bioanalytics GmbH (“Accelero”) has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples.
Berlin, 23 March 2020
Accelero Bioanalytics GmbH (“Accelero”) has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples.
Accelero invites you to read our blog and case studies on
www.binding-assay.com